<DOC>
	<DOC>NCT01806818</DOC>
	<brief_summary>Multi-center Study to Compare Efficacy and Safety between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients during 7 days.</brief_summary>
	<brief_title>Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Eperisone</mesh_term>
	<criteria>Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing 20≤ age ≤60 A patient has symptom of acute low back pain 4≤ VAS Subjects who cannot prohibit antiinflammatory drug, painkiller or muscle relaxants during clinical trial Chronic rheumatoid arthritis patients Patients having a medical history of hypersensitivity to Eperisone Hydrochloride Subject having a hereditary problem such as galactose intolerance, Lapp lactase deficiency, or glucose galatose malabsorption Participation in other studies before 60 days of first dosing Female patients having positive pregnancy test, lactating women,planning pregnancy during clinical trial Inadequate subject for the clinical trial by the investigator's decision</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>